Riskpilot← Back to searchSign inGet full accessMEDITEKNIKK AS
ASActiveOrg 885962572Nordliveien 2, 1671 KråkerøyTechnical testing and analysis · NACE 7120Est. 20031 employees
Revenue 2025
NOK 557K
-33% vs 2024
EBITDA margin
32.3%
-54% vs 2024
Equity ratio
81.5%
Financial strength
Net profit 2025
NOK 140K
-54% vs 2024
| Revenue | NOK 557K | -33% |
| EBITDA | NOK 180K | -54% |
| Net profit | NOK 140K | -54% |
| Total assets | NOK 587K | +18% |
| Equity | NOK 478K | +42% |
| Employees | 1 | — |
Legal name
MEDITEKNIKK AS
Org number
885962572
Legal form
Aksjeselskap
NACE code
7120 · Technical testing and analysis
Founded
26. august 2003
Share capital
NOK 35 454
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Kvalitetssikring, registrering og vedlikehold av medisinsk utstyr. Kjøp og salg av deler og tilbehør til medisinsk utstyr. Forskning og utvikling av hjelpemidler og medisinsk utstyr. Konsulenttjenester innen it og medisinteknikk og alt som herved står i forbindelse. Selskapet kan videre delta i annen virksomhet gjennom aksjetegning eller annet.
Address
Nordliveien 2, 1671 Kråkerøy
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 62 | 69 | 245 | 502 | 548 | 574 | 790 | 782 | 970 | 1 195 | 1 354 | 1 424 | 1 636 | 1 681 | 1 635 | 1 706 | 827 | 557 |
| Staff expenses | −0 | −0 | −0 | −1 | −2 | −2 | −304 | −371 | −380 | −468 | −565 | −614 | −655 | −750 | −729 | −826 | −792 | −345 | −214 |
| EBITDA | 0 | 42 | 29 | 85 | 199 | 220 | 152 | 329 | 267 | 397 | 439 | 563 | 571 | 693 | 748 | 601 | 517 | 391 | 180 |
| Depreciation & amort. | −0 | −6 | −6 | −6 | −9 | −10 | −10 | −6 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | 0 | 36 | 23 | 79 | 190 | 210 | 142 | 322 | 267 | 397 | 439 | 563 | 571 | 693 | 748 | 601 | 517 | 391 | 180 |
| Net financials | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | −0 | 0 | −0 | −2 | 0 | 1 | 1 |
| Profit before tax | 0 | 37 | 23 | 79 | 191 | 211 | 143 | 323 | 267 | 398 | 439 | 563 | 571 | 693 | 748 | 599 | 517 | 392 | 181 |
| Tax | −0 | 10 | 6 | 22 | 53 | 59 | 40 | 87 | 72 | 99 | 105 | 130 | 126 | 152 | 165 | 132 | 114 | 88 | 40 |
| Net profit | 0 | 27 | 17 | 57 | 137 | 152 | 103 | 236 | 195 | 298 | 334 | 434 | 445 | 540 | 584 | 467 | 403 | 305 | 140 |
| Item | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | — | 115 | 154 | 254 | 381 | 541 | 300 | 626 | 388 | 770 | 653 | 795 | 890 | 1 059 | 1 094 | 1 066 | 990 | 497 | 587 |
| Equity | — | 113 | 130 | 186 | 324 | 126 | 228 | 119 | 225 | 34 | 38 | 30 | 31 | 571 | 32 | 32 | 33 | 338 | 478 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 3 | 25 | 68 | 58 | 415 | 71 | 508 | 163 | 736 | 615 | 765 | 859 | 488 | 1 063 | 1 034 | 957 | 159 | 109 |
| Total debt | 0 | 3 | 25 | 68 | 58 | 415 | 71 | 508 | 163 | 736 | 615 | 765 | 859 | 488 | 1 063 | 1 034 | 957 | 159 | 109 |
EBITDA margin
32.3%
This company
15.8%
Market median
+104% vs market
20072025
Equity ratio
81.5%
This company
38.2%
Market median
+113% vs market
20072025
Return on equity
29.3%
This company
18.4%
Market median
+59% vs market
20072025
Net profit margin
25.2%
This company
8.1%
Market median
+211% vs market
20072025
Asset turnover
0.95×
This company
1.12×
Market median
+15% vs market
20072025
Debt / equity
0.23×
This company
0.62×
Market median
+63% vs market
20072025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-01-01 – 2009-12-31
- Annual report 2008Filed via Brønnøysundsregistrene · Period 2008-01-01 – 2008-12-31
- Annual report 2007Filed via Brønnøysundsregistrene · Period 2007-01-01 – 2007-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
HP Chief Executive Officer | Chief Executive Officer | 2003 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 13.3% | 13.3% | 2024 | |
| Individual | 13.3% | 13.3% | 2022 | |
| Individual | 13.3% | 13.3% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MEDITEKNIKK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hans Petter Steine Olsen | Chief Executive Officer | 0 companies |
| Jan Bjørkelo | Chairman | 0 companies |